Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Scope of Consolidation - Schedule of list of companies directly or indirectly controlled (Details)

v3.24.0.1
Scope of Consolidation - Schedule of list of companies directly or indirectly controlled (Details)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Nuova Ompi S.r.l.    
Disclosure Of Significant Investments In Subsidiaries [Line Items]    
Segment Biopharmaceutical and Diagnostic Solutions  
Description Production of drug containment solutions and development of integrated solutions for the pharmaceutical industry  
Country of incorporation   Italy
% equity interest 100.00% 100.00%
Spami S.r.l.    
Disclosure Of Significant Investments In Subsidiaries [Line Items]    
Segment Engineering  
Description Production plant and machinery  
Country of incorporation   Italy
% equity interest 100.00% 100.00%
Stevanato Group International a.s.    
Disclosure Of Significant Investments In Subsidiaries [Line Items]    
Segment Holding  
Description Service/Subholding company  
Country of incorporation   Slovakia
% equity interest 100.00% 100.00%
Medical Glass a.s.    
Disclosure Of Significant Investments In Subsidiaries [Line Items]    
Segment Biopharmaceutical and Diagnostic Solutions  
Description Production of drug containment solutions  
Country of incorporation Slovakia Slovakia
% equity interest 99.74% 99.74%
Stevanato Group N.A. S. de RL de CV    
Disclosure Of Significant Investments In Subsidiaries [Line Items]    
Segment Biopharmaceutical and Diagnostic Solutions  
Description Service company  
Country of incorporation   Mexico
% equity interest 100.00% 100.00%
Ompi N.A. S. de R.L. de C.V.    
Disclosure Of Significant Investments In Subsidiaries [Line Items]    
Segment Biopharmaceutical and Diagnostic Solutions  
Description Production of drug containment solutions  
Country of incorporation   Mexico
% equity interest 100.00% 100.00%
Ompi of America inc.    
Disclosure Of Significant Investments In Subsidiaries [Line Items]    
Segment Biopharmaceutical and Diagnostic Solutions  
Description Sale of drug containment solutions and analytical services  
Country of incorporation   USA
% equity interest 100.00% 100.00%
Ompi do Brasil I. e C. de Em. Far. Ltda    
Disclosure Of Significant Investments In Subsidiaries [Line Items]    
Segment Biopharmaceutical and Diagnostic Solutions  
Description Production of drug containment solutions  
Country of incorporation   Brazil
% equity interest 100.00% 100.00%
Perugini S.r.l.    
Disclosure Of Significant Investments In Subsidiaries [Line Items]    
Segment Engineering  
Description Production of consumables and mechanical components for industrial machines  
Country of incorporation   Italy
% equity interest 100.00%  
Ompi Pharm. Packing Techn. Co. Ltd    
Disclosure Of Significant Investments In Subsidiaries [Line Items]    
Segment Biopharmaceutical and Diagnostic Solutions  
Description Production of drug containment solutions  
Country of incorporation   China
% equity interest 100.00% 100.00%
Stevanato Group Denmark A/S    
Disclosure Of Significant Investments In Subsidiaries [Line Items]    
Segment Engineering  
Description Production plant and machinery  
Country of incorporation   Denmark
% equity interest 100.00% 100.00%
Medirio SA    
Disclosure Of Significant Investments In Subsidiaries [Line Items]    
Segment Biopharmaceutical and Diagnostic Solutions  
Description Research and development  
Country of incorporation   Switzerland
% equity interest 100.00% 100.00%
Balda Medical Gmbh    
Disclosure Of Significant Investments In Subsidiaries [Line Items]    
Segment Biopharmaceutical and Diagnostic Solutions  
Description Production of in-vitro diagnostic solutions  
Country of incorporation   Germany
% equity interest 100.00% 100.00%
Balda C. Brewer Inc.    
Disclosure Of Significant Investments In Subsidiaries [Line Items]    
Segment Biopharmaceutical and Diagnostic Solutions  
Description Production of in-vitro diagnostic solutions  
Country of incorporation   USA
% equity interest 100.00% 100.00%
Balda Precision Inc.    
Disclosure Of Significant Investments In Subsidiaries [Line Items]    
Segment Biopharmaceutical and Diagnostic Solutions  
Description Production metal components  
Country of incorporation   USA
% equity interest 100.00% 100.00%
Ompi of Japan Co., Ltd.    
Disclosure Of Significant Investments In Subsidiaries [Line Items]    
Segment Biopharmaceutical and Diagnostic Solutions  
Description Sale of drug containment solutions  
Country of incorporation Japan Japan
% equity interest 100.00% 51.00%